Why Vertex Pharma Popped, As A Key Rival Plummeted 90%

The coverage curve

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Coverage (9)

• 
  Sionna Therapeutics stock falls 92% after SION-719 trial failure qz.com · 46d ago
• 
  Sionna Therapeutics stock plunges nearly 100% after cystic fibrosis drug fails key trial The Business Journals · 46d ago
• 
  SION Stock On Track For Worst Day Ever After 90% Drop Yahoo Finance · 46d ago
• 
  Why Sionna Therapeutics Stock Is Crashing 92% to a Record Low Barron's · 46d ago
• 
  Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial STAT · 46d ago
• 
  Sionna’s cystic fibrosis flop sends stock down 90%, but a ‘significant positive’ for Vertex Fierce Biotech · 46d ago
• 
  Sionna Won’t Advance Add-On Drug After CF Trial Misses Goal Stock Titan · 46d ago
• 
  Sionna Therapeutics shares collapse 92% after cystic fibrosis trial misses key endpoint Yahoo Finance · 46d ago
• 
  Why Vertex Pharma Popped, As A Key Rival Plummeted 90% Investor's Business Daily · 46d ago broke it first

Related trends